Search Content | UT Health San Antonio MD Anderson Cancer Center

Search Result for "*:*"

Research & Publications

Novel LHRH-receptor-targeted cytolytic peptide, EP-100: first-in-human phase I study in patients with advanced LHRH-receptor-expressing solid tumors.

Research & Publications

Relative bioavailability of a prototype oral solution of the Aurora A kinase inhibitor alisertib (MLN8237) in patients with advanced solid tumors.

Research & Publications

Safety, pharmacokinetics, and activity of GRN1005, a novel conjugate of angiopep-2, a peptide facilitating brain penetration, and paclitaxel, in patients with advanced solid tumors.

Research & Publications

Feasibility of using American Joint Committee on Cancer Classification criteria for staging eyelid carcinomas.

Research & Publications

Prospective collection of data using the 7th edition of the AJCC Cancer Staging Manual for cancers of the eyelid, orbit, and conjunctiva.

Research & Publications

Intratumoral CD56(bright) natural killer cells are associated with improved survival in bladder cancer.

Research & Publications

Percutaneous BCG enhances innate effector antitumor cytotoxicity during treatment of bladder cancer: a translational clinical trial.

Research & Publications

Rapamycin Prevents Surgery-Induced Immune Dysfunction in Patients with Bladder Cancer.

Cancer Treatment

Brachytherapy

Brachytherapy, also called internal radiation therapy, can effectively treat certain cancers, such as cervical and breast cancers, in novel ways. At Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, you receive care from skilled experts who are leaders in their field. Our experienced radiation oncologists perform intricate brachytherapy procedures with your safety and comfort in mind at all times.

Cancer Type

Multiple Myeloma